Markets.com Logo

NWBO

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    0.2411$
  • Previous Close
    0.2481$
  • 52 Week Change
    0.31$
  • Day Range
    -0.01$
  • 52 Week High/Low
    0.17$ - 0.48$
  • Dividend Per Share
    --
  • Market cap
    371 M$
  • EPS
    -0.01
  • Beta
    -1.139
  • Volume
    --

About

NWBO.US represents the stock of Northwest Biotherapeutics, Inc., a biotechnology company focused on developing personalized immune therapies for solid tumor cancers. Their lead product candidate is DCVax-L, a personalized immune therapy for newly diagnosed glioblastoma, the most aggressive and common form of brain cancer. Northwest Biotherapeutics' stock trades on the OTCQB Venture Market under the symbol NWBO.US. Investors should be aware that companies trading on the OTC markets often carry higher risk and may have less stringent reporting requirements compared to those listed on major exchanges. The company's financial performance and clinical trial outcomes are key factors that can impact the stock price.

Gold's Safe-Haven Status Under Scrutiny: Market Dynamics and Price Outlook

Emma Rose|--

Trump's Iran War Exit Without a Deal: Reshaping Middle East Energy Security and Power Dynamics

Emma Rose|--
European market insights: What is the European stock market doing right now?

European market insights: What is the European stock market doing right now?

Ghko B|--
EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

Ghko B|--

Microsoft at a Crossroads: AI Hurdles and Cloud Resilience Amidst Market Volatility

Sophia Claire|--

Iran's Hormuz Gambit: Leveraging a Chokepoint for Economic Leverage and Global Impact

Ava Grace|--

Gold Market Resilience: Navigating Sell-offs and Sustaining Bull Run

Noah Lee|--

Factors

Clinical Trial Results: Positive trial outcomes often lead to significant stock price increases, while negative results can cause substantial declines.

Regulatory Decisions: FDA approvals or rejections of NWBO's treatments directly impact investor confidence and stock value.

Financial Performance: The company's cash position, revenue, and profitability affect investor perception of its long-term viability.

Market Sentiment: Overall market trends and investor optimism or pessimism regarding the biotechnology sector can influence NWBO's stock price.

Competition: The emergence of competing therapies or companies in the same market can impact NWBO's perceived market share and future revenue.

News and Announcements: Company-specific news, such as partnerships, acquisitions, or management changes, can trigger price fluctuations.

Trading Volume: High trading volume can indicate increased investor interest and potential price volatility.

Analyst Ratings: Recommendations from financial analysts can influence investor decisions and affect the stock price.

Economic Conditions: Broader economic factors, such as interest rates and inflation, can indirectly impact investor sentiment and investment decisions.

Patent Protection: The strength and duration of NWBO's patents protect their product exclusivity and drive investment decisions.

People Also Watch

Latest news

US Steel and Aluminum Tariffs Revamped: Simplification Amidst Potential Cost Increases

Noah Lee|--

SpaceX Files Secret IPO Bid, Eyeing Record-Breaking $1.75 Trillion Valuation

Ava Grace|--

US Intelligence: Iran Unwilling to Engage in Substantive Talks to End War

Sophia Claire|--

Latest Education Articles

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

Ghko B|--
Investing basics for beginners: What are the 4 economic indicators?

Investing basics for beginners: What are the 4 economic indicators?

Frances Wang|--
CFDs vs Options: What’s the Difference?

CFDs vs Options: What’s the Difference?

Julian Parker|--